— Know what they know.
Not Investment Advice
Also trades as: 0R29.L (LSE) · $vol 2M

ISRG NASDAQ

Intuitive Surgical, Inc.
1W: +2.7% 1M: -9.1% 3M: -12.8% YTD: -21.7% 1Y: -21.1% 3Y: +43.4% 5Y: +58.3%
$438.10
-1.70 (-0.39%)
 
Weekly Expected Move ±5.9%
$372 $396 $421 $446 $470
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 42 · $155.2B mcap · 352M float · 0.564% daily turnover · Short 44% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
68.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 22.1%  ·  5Y Avg: 25.1%
Cost Advantage
79
Intangibles
55
Switching Cost
52
Network Effect
80
Scale ★
95
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ISRG has a Narrow competitive edge (68.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 22.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$651
Low
$651
Avg Target
$651
High
Based on 1 analyst since Apr 21, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 38Hold: 12Sell: 5Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$581.50
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-23 Barclays $712 $651 -61 +34.6% $483.62
2026-04-15 Truist Financial $650 $580 -70 +22.9% $472.02
2026-04-13 Mizuho Securities $575 $525 -50 +16.5% $450.47
2026-02-24 UBS $600 $570 -30 +16.1% $491.00
2026-01-26 Barclays $686 $712 +26 +35.9% $523.99
2026-01-23 Evercore ISI Vijay Kumar $580 $550 -30 +5.0% $523.60
2026-01-23 Piper Sandler $610 $620 +10 +17.9% $525.81
2026-01-23 Bernstein $740 $750 +10 +42.6% $525.81
2026-01-09 Bernstein $685 $740 +55 +26.5% $585.08
2026-01-09 Goldman Sachs $604 $714 +110 +22.0% $585.08
2026-01-07 BTIG $589 $616 +27 +3.9% $592.85
2026-01-07 Barclays $314 $686 +372 +15.7% $592.85
2026-01-05 Evercore ISI $490 $580 +90 +2.5% $565.96
2025-12-18 Truist Financial $620 $650 +30 +14.9% $565.57
2025-12-17 RBC Capital Shagun Singh $625 $650 +25 +17.2% $554.58
2025-10-23 UBS $529 $600 +71 +13.8% $527.03
2025-10-22 Mizuho Securities Anthony Petrone $550 $575 +25 +24.3% $462.74
2025-10-22 Truist Financial Richard Newitter $525 $620 +95 +34.0% $462.74
2025-10-22 RBC Capital $555 $625 +70 +35.1% $462.74
2025-10-22 Raymond James $330 $603 +273 +30.3% $462.74
2025-10-22 Robert W. Baird $600 $655 +55 +41.5% $462.74
2025-10-22 Piper Sandler Adam Maeder $538 $610 +72 +31.8% $462.74
2025-10-22 BTIG $566 $589 +23 +27.3% $462.74
2025-10-21 Bernstein Lee Hambright Initiated $685 +47.6% $464.07
2025-10-15 Truist Financial $605 $525 -80 +20.2% $436.62
2025-10-13 UBS Initiated $529 +23.1% $429.59
2025-07-14 BTIG Ryan Zimmerman $560 $566 +6 +8.9% $519.89
2025-04-14 BTIG Ryan Zimmerman $535 $560 +25 +14.3% $490.13
2025-03-18 Robert W. Baird $565 $600 +35 +24.0% $483.95
2025-03-17 Truist Financial $640 $605 -35 +23.8% $488.80
2024-12-18 Truist Financial Richard Newitter $570 $640 +70 +21.6% $526.47
2024-12-02 Morgan Stanley Patrick Wood $475 $650 +175 +19.9% $541.93
2024-10-18 Goldman Sachs David Roman $500 $604 +104 +16.6% $517.97
2024-10-18 RBC Capital Shagun Singh $525 $555 +30 +17.2% $473.73
2024-10-18 Piper Sandler Adam Maeder $495 $538 +43 +13.6% $473.73
2024-10-18 Mizuho Securities Anthony Petrone Initiated $550 +16.1% $473.73
2024-10-18 Stifel Nicolaus Rick Wise $475 $525 +50 +10.8% $473.73
2024-10-18 Truist Financial Richard Newitter $520 $570 +50 +20.3% $473.73
2024-10-18 Evercore ISI Vijay Kumar $475 $490 +15 +3.4% $473.73
2024-10-18 BTIG Ryan Zimmerman $518 $535 +17 +12.9% $473.73
2024-10-15 Robert W. Baird David Rescott $436 $565 +129 +15.9% $487.61
2024-10-15 Wells Fargo Larry Biegelsen $305 $466 +161 -4.4% $487.61
2024-10-14 BTIG Ryan Zimmerman $421 $518 +97 +6.9% $484.78
2024-10-08 RBC Capital Shagun Singh $355 $525 +170 +11.4% $471.23
2024-10-01 Evercore ISI Vijay Kumar $410 $475 +65 -3.3% $491.27
2024-08-22 Citigroup Joanne Wuensch Initiated $560 +14.9% $487.42
2024-07-19 Morgan Stanley Drew Ranieri $290 $475 +185 +5.2% $451.61
2024-07-19 Evercore ISI Vijay Kumar $294 $410 +116 -1.5% $416.14
2024-07-19 Stifel Nicolaus Rick Wise $430 $475 +45 +14.1% $416.14
2024-07-19 Truist Financial Richard Newitter $515 $520 +5 +14.3% $455.01

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
3
ROE
5
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ISRG receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-04 B- B
2026-04-21 B B-
2026-04-01 B+ B
2026-02-11 C- B+
2026-01-23 B- C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

80 Grade A+
Profitability
87
Balance Sheet
96
Earnings Quality
77
Growth
71
Value
29
Momentum
91
Safety
100
Cash Flow
87
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ISRG scores highest in Safety (100/100) and lowest in Value (29/100). An overall grade of A+ places ISRG among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
38.97
Safe Zone
Piotroski F-Score
9/9
Beneish M-Score
-2.46
Unlikely Manipulator
Ohlson O-Score
-13.40
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 92.8/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.13x
Accruals: -1.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ISRG scores 38.97, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ISRG scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ISRG's score of -2.46 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ISRG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ISRG receives an estimated rating of AA+ (score: 92.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ISRG's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
52.19x
PEG
2.53x
P/S
14.66x
P/B
8.90x
P/FCF
58.52x
P/OCF
49.35x
EV/EBITDA
41.64x
EV/Revenue
15.14x
EV/EBIT
48.39x
EV/FCF
56.53x
Earnings Yield
1.80%
FCF Yield
1.71%
Shareholder Yield
2.06%
Graham Number
$96.07
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 52.2x earnings, ISRG is priced for high growth expectations. Graham's intrinsic value formula yields $96.07 per share, 356% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.831
NI / EBT
×
Interest Burden
1.082
EBT / EBIT
×
EBIT Margin
0.313
EBIT / Rev
×
Asset Turnover
0.536
Rev / Assets
×
Equity Multiplier
1.152
Assets / Equity
=
ROE
17.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ISRG's ROE of 17.4% is driven by Asset Turnover (0.536), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
30.97%
Fair P/E
70.44x
Intrinsic Value
$583.28
Price/Value
0.79x
Margin of Safety
20.97%
Premium
-20.97%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ISRG's realized 31.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $583.28, ISRG appears undervalued with a 21% margin of safety. The adjusted fair P/E of 70.4x compares to the current market P/E of 52.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$438.10
Median 1Y
$465.66
5th Pctile
$256.94
95th Pctile
$844.74
Ann. Volatility
34.4%
Analyst Target
$581.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David J. Rosa
Chief Executive Officer
$858,750 $18,674,872 $20,997,480
Gary S. Guthart,
Ph.D. Executive Chair of the Board of Directors
$866,250 $15,954,662 $18,094,937
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Enterprise Technology Leader
$683,000 $6,914,229 $8,396,045
Henry L. Charlton
Executive Vice President and Chief Commercial and Marketing Officer
$670,000 $4,786,863 $6,240,703
Gary H. Loeb
Executive Vice President and Chief Legal and Compliance Officer
$615,000 $4,254,731 $5,590,211
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
$534,350 $4,520,797 $5,539,390

CEO Pay Ratio

150:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $20,997,480
Avg Employee Cost (SGA/emp): $140,121
Employees: 17,021

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
17,021
+8.8% YoY
Revenue / Employee
$591,311
Rev: $10,064,700,000
Profit / Employee
$167,793
NI: $2,856,000,000
SGA / Employee
$140,121
Avg labor cost proxy
R&D / Employee
$77,070
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 18.0% 18.7% 15.7% 15.1% 13.2% 12.7% 11.5% 11.4% 12.4% 13.2% 14.8% 16.3% 17.2% 18.4% 15.6% 16.7% 17.5% 18.5% 16.7% 17.4% 17.39%
ROA 15.5% 16.2% 13.8% 13.3% 11.6% 11.1% 10.0% 9.9% 10.7% 11.4% 12.7% 14.0% 14.7% 15.8% 13.6% 14.4% 15.2% 16.0% 14.5% 15.1% 15.10%
ROIC 32.6% 35.5% 21.3% 20.9% 18.3% 17.7% 19.1% 18.5% 19.7% 20.5% 20.3% 22.1% 22.8% 24.2% 16.3% 17.4% 18.5% 19.6% 21.0% 22.1% 22.12%
ROCE 15.8% 17.5% 14.7% 14.6% 13.7% 13.3% 13.7% 13.5% 14.0% 14.6% 12.8% 13.4% 14.2% 15.0% 13.7% 14.4% 15.9% 17.0% 16.3% 17.8% 17.78%
Gross Margin 69.9% 69.2% 68.4% 67.9% 67.2% 67.6% 67.1% 65.6% 66.7% 66.9% 66.2% 65.9% 68.3% 67.4% 68.0% 64.7% 66.4% 66.4% 66.4% 66.1% 66.06%
Operating Margin 34.9% 31.5% 29.0% 27.4% 26.1% 25.6% 22.5% 22.9% 26.4% 26.7% 23.3% 24.8% 28.2% 28.3% 30.4% 25.7% 30.5% 30.3% 30.2% 30.9% 30.87%
Net Margin 35.3% 27.1% 24.5% 24.6% 20.2% 20.8% 19.6% 20.9% 24.0% 23.8% 31.4% 28.8% 26.2% 27.7% 28.4% 31.0% 27.0% 28.1% 27.7% 29.6% 29.65%
EBITDA Margin 40.1% 37.4% 34.3% 33.1% 31.8% 31.4% 28.9% 28.3% 31.9% 32.9% 29.7% 30.6% 33.8% 34.0% 35.6% 31.9% 40.5% 36.7% 37.9% 30.9% 30.87%
FCF Margin 32.2% 34.3% 30.4% 24.5% 21.7% 17.6% 15.4% 15.7% 17.7% 18.3% 10.5% 8.1% 5.5% 7.4% 15.6% 20.0% 21.8% 23.6% 24.7% 26.8% 26.78%
OCF Margin 37.2% 39.2% 36.6% 31.1% 29.2% 26.5% 24.0% 25.5% 27.9% 29.5% 25.5% 23.3% 22.0% 23.1% 28.9% 31.3% 30.9% 30.8% 30.1% 31.8% 31.76%
ROE 3Y Avg snapshot only 15.57%
ROE 5Y Avg snapshot only 14.47%
ROA 3Y Avg snapshot only 13.49%
ROIC 3Y Avg snapshot only 21.38%
ROIC Economic snapshot only 15.05%
Cash ROA snapshot only 16.29%
Cash ROIC snapshot only 27.57%
CROIC snapshot only 23.25%
NOPAT Margin snapshot only 25.49%
Pretax Margin snapshot only 33.86%
R&D / Revenue snapshot only 12.83%
SGA / Revenue snapshot only 23.01%
SBC / Revenue snapshot only 7.68%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 68.92 71.96 77.44 67.29 50.92 49.04 71.64 69.32 85.74 69.03 67.21 72.38 76.70 79.44 81.78 72.93 75.88 58.91 71.47 55.68 52.191
P/S Ratio 21.66 22.15 23.12 18.73 12.25 11.04 15.22 14.14 18.33 15.28 16.96 19.66 21.21 22.65 22.74 20.72 21.64 16.83 20.28 15.67 14.662
P/B Ratio 11.46 12.46 11.05 9.26 6.11 5.65 8.58 8.24 11.06 9.48 9.08 10.81 12.07 13.39 11.56 10.99 12.04 9.85 11.45 9.31 8.898
P/FCF 67.29 64.49 76.05 76.57 56.44 62.86 98.84 90.24 103.63 83.29 161.21 241.48 382.81 304.07 145.68 103.46 99.21 71.24 81.95 58.52 58.520
P/OCF 58.17 56.56 63.18 60.29 42.01 41.70 63.54 55.48 65.75 51.74 66.62 84.24 96.59 97.87 78.65 66.12 70.01 54.65 67.35 49.35 49.353
EV/EBITDA 55.83 55.54 60.00 49.88 33.91 31.79 46.64 44.96 58.79 48.03 52.83 60.62 64.59 68.51 66.20 59.88 59.51 45.31 53.48 41.64 41.645
EV/Revenue 20.66 21.20 22.39 18.03 11.55 10.37 14.56 13.50 17.71 14.68 16.23 18.94 20.52 21.99 22.28 20.28 21.21 16.43 19.72 15.14 15.142
EV/EBIT 66.07 65.15 70.22 58.76 40.56 38.33 57.45 55.78 72.78 59.55 65.44 75.00 79.57 83.79 79.22 71.90 71.26 54.37 65.42 48.39 48.388
EV/FCF 64.18 61.75 73.66 73.70 53.24 59.00 94.55 86.16 100.13 80.02 154.24 232.71 370.36 295.15 142.72 101.25 97.27 69.54 79.69 56.53 56.533
Earnings Yield 1.5% 1.4% 1.3% 1.5% 2.0% 2.0% 1.4% 1.4% 1.2% 1.4% 1.5% 1.4% 1.3% 1.3% 1.2% 1.4% 1.3% 1.7% 1.4% 1.8% 1.80%
FCF Yield 1.5% 1.6% 1.3% 1.3% 1.8% 1.6% 1.0% 1.1% 1.0% 1.2% 0.6% 0.4% 0.3% 0.3% 0.7% 1.0% 1.0% 1.4% 1.2% 1.7% 1.71%
PEG Ratio snapshot only 2.533
Price/Tangible Book snapshot only 9.509
EV/OCF snapshot only 47.677
EV/Gross Profit snapshot only 22.831
Acquirers Multiple snapshot only 49.720
Shareholder Yield snapshot only 2.06%
Graham Number snapshot only $96.07
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.86 6.86 5.08 5.08 5.08 5.08 4.40 4.40 4.40 4.40 4.76 4.76 4.76 4.76 4.07 4.07 4.07 4.07 4.87 4.87 4.875
Quick Ratio 6.24 6.24 4.57 4.57 4.57 4.57 3.77 3.77 3.77 3.77 4.02 4.02 4.02 4.02 3.22 3.22 3.22 3.22 3.96 3.96 3.957
Debt/Equity 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.017
Net Debt/Equity -0.53 -0.53 -0.35 -0.35 -0.35 -0.35 -0.37 -0.37 -0.37 -0.37 -0.39 -0.39 -0.39 -0.39 -0.24 -0.24 -0.24 -0.24 -0.32 -0.32 -0.316
Debt/Assets 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.015
Debt/EBITDA 0.00 0.00 0.04 0.04 0.04 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.05 0.04 0.04 0.08 0.08 0.079
Net Debt/EBITDA -2.71 -2.47 -1.94 -1.94 -2.04 -2.08 -2.12 -2.13 -2.05 -1.97 -2.39 -2.28 -2.17 -2.07 -1.38 -1.31 -1.19 -1.11 -1.52 -1.46 -1.464
Interest Coverage
Equity Multiplier 1.14 1.14 1.13 1.13 1.13 1.13 1.17 1.17 1.17 1.17 1.16 1.16 1.16 1.16 1.15 1.15 1.15 1.15 1.16 1.16 1.157
Cash Ratio snapshot only 2.958
Cash to Debt snapshot only 19.600
FCF to Debt snapshot only 9.360
Defensive Interval snapshot only 727.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.49 0.53 0.46 0.48 0.48 0.49 0.47 0.48 0.50 0.52 0.50 0.52 0.53 0.55 0.49 0.51 0.53 0.56 0.51 0.54 0.536
Inventory Turnover 2.70 2.83 2.95 3.10 3.19 3.32 2.74 2.88 2.99 3.09 2.27 2.32 2.37 2.46 2.01 2.12 2.25 2.38 2.06 2.14 2.142
Receivables Turnover 8.00 8.50 8.00 8.27 8.35 8.57 7.21 7.46 7.73 7.94 6.88 7.06 7.31 7.59 7.09 7.40 7.76 8.16 7.31 7.69 7.689
Payables Turnover 15.76 16.53 17.27 18.15 18.72 19.45 15.11 15.89 16.53 17.06 14.27 14.64 14.95 15.48 14.23 15.01 15.96 16.90 15.25 15.89 15.892
DSO 46 43 46 44 44 43 51 49 47 46 53 52 50 48 51 49 47 45 50 47 47.5 days
DIO 135 129 124 118 114 110 133 127 122 118 161 157 154 149 182 172 162 153 178 170 170.4 days
DPO 23 22 21 20 19 19 24 23 22 21 26 25 24 24 26 24 23 22 24 23 23.0 days
Cash Conversion Cycle 158 150 148 142 138 134 160 153 147 143 189 184 179 173 208 197 186 176 204 195 194.9 days
Fixed Asset Turnover snapshot only 1.981
Operating Cycle snapshot only 217.9 days
Cash Velocity snapshot only 1.783
Capital Intensity snapshot only 1.950
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 18.5% 27.4% 31.0% 29.8% 15.5% 11.5% 9.0% 8.9% 11.7% 12.0% 14.5% 13.8% 13.6% 14.8% 17.2% 19.1% 20.8% 22.2% 20.5% 21.4% 21.43%
Net Income 42.8% 60.4% 60.7% 40.1% -11.6% -18.4% -22.4% -20.2% -0.7% 10.1% 36.0% 51.5% 46.9% 47.9% 29.2% 24.6% 24.5% 22.5% 23.0% 20.3% 20.31%
EPS 40.6% 58.2% 58.9% 38.6% -11.4% -17.0% -20.2% -17.8% 1.2% 10.8% 35.5% 49.6% 45.4% 46.1% 27.2% 23.2% 23.5% 22.8% 24.2% 21.9% 21.92%
FCF 52.8% 90.7% 51.8% 9.9% -22.1% -43.0% -44.8% -30.2% -8.9% 16.9% -21.8% -40.9% -64.4% -53.4% 73.9% 1.9% 3.8% 2.9% 91.0% 62.4% 62.40%
EBITDA 39.6% 62.2% 60.7% 45.4% 6.3% -4.8% -8.8% -9.5% -1.1% 4.9% 12.6% 18.4% 19.8% 20.6% 28.4% 29.0% 35.5% 38.1% 32.0% 30.4% 30.37%
Op. Income 43.2% 73.2% 73.5% 53.1% 5.2% -7.4% -13.4% -14.1% -4.5% 2.1% 12.0% 18.8% 20.4% 22.2% 32.9% 32.9% 34.9% 36.4% 25.4% 31.1% 31.13%
OCF Growth snapshot only 23.05%
Asset Growth snapshot only 9.52%
Equity Growth snapshot only 8.46%
Debt Growth snapshot only 1.07%
Shares Change snapshot only -1.32%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 14.3% 15.4% 15.3% 15.3% 13.9% 12.9% 11.6% 11.8% 15.2% 16.7% 17.8% 17.2% 13.6% 12.8% 13.5% 13.8% 15.3% 16.3% 17.4% 18.1% 18.06%
Revenue 5Y 15.3% 15.9% 16.1% 16.2% 15.8% 15.4% 14.7% 14.3% 14.0% 13.9% 13.9% 13.7% 13.4% 13.1% 13.3% 13.6% 16.0% 17.4% 18.2% 18.4% 18.38%
EPS 3Y 23.7% 27.4% 12.4% 11.9% 5.3% 1.4% -1.2% -1.5% 8.0% 13.3% 19.8% 19.5% 9.2% 10.3% 11.2% 14.8% 22.0% 25.7% 28.9% 31.0% 30.97%
EPS 5Y 18.3% 17.9% 17.7% 14.8% 10.8% 8.2% 13.6% 11.2% 11.2% 13.7% 9.0% 11.5% 11.4% 11.0% 10.7% 12.0% 17.8% 21.1% 22.1% 20.7% 20.69%
Net Income 3Y 26.5% 28.5% 14.8% 12.8% 5.8% 1.6% -1.4% -1.8% 7.8% 12.9% 19.2% 19.2% 8.9% 9.9% 10.9% 14.6% 22.0% 25.9% 29.3% 31.4% 31.44%
Net Income 5Y 19.1% 18.5% 18.3% 16.1% 11.9% 8.8% 14.9% 11.3% 12.2% 13.7% 9.8% 11.6% 11.6% 11.3% 11.0% 12.3% 18.1% 21.1% 21.9% 20.5% 20.48%
EBITDA 3Y 14.7% 17.1% 17.4% 17.7% 13.0% 10.4% 7.2% 5.8% 13.6% 17.5% 18.2% 15.9% 8.0% 6.4% 9.7% 11.4% 17.1% 20.4% 24.1% 25.8% 25.83%
EBITDA 5Y 14.8% 15.5% 15.4% 15.2% 13.7% 12.8% 10.9% 9.2% 9.7% 9.9% 10.7% 11.8% 11.3% 11.3% 12.2% 12.6% 18.9% 22.0% 22.9% 21.3% 21.25%
Gross Profit 3Y 13.5% 14.9% 15.0% 14.9% 13.1% 12.0% 10.5% 10.6% 15.0% 16.8% 18.2% 17.1% 12.6% 11.6% 12.5% 12.9% 14.5% 15.5% 16.6% 17.7% 17.75%
Gross Profit 5Y 15.4% 15.8% 15.9% 15.8% 15.1% 14.7% 13.8% 13.1% 12.9% 12.8% 12.7% 12.7% 12.5% 12.3% 12.6% 13.0% 15.8% 17.4% 18.4% 18.3% 18.33%
Op. Income 3Y 11.7% 14.4% 14.9% 15.5% 10.6% 8.1% 4.7% 3.5% 12.9% 17.9% 18.9% 16.0% 6.6% 4.9% 8.9% 10.7% 15.7% 19.4% 23.1% 27.5% 27.45%
Op. Income 5Y 13.4% 14.0% 14.0% 13.6% 11.9% 10.8% 8.4% 6.4% 6.9% 7.2% 8.1% 9.5% 9.2% 9.5% 11.3% 11.8% 18.5% 22.2% 22.9% 22.2% 22.18%
FCF 3Y 17.3% 23.5% 20.9% 14.6% 8.7% 1.0% -6.5% -5.7% 2.7% 8.3% -13.1% -23.2% -36.8% -32.3% -9.1% 6.5% 15.5% 28.3% 37.5% 41.2% 41.15%
FCF 5Y 14.3% 14.8% 11.9% 8.1% 7.5% 2.3% 0.1% 0.1% 2.7% 4.7% -5.3% -9.1% -16.1% -10.9% 2.1% 7.7% 12.9% 18.1% 16.9% 16.6% 16.61%
OCF 3Y 17.1% 22.7% 21.3% 14.5% 10.0% 5.4% -2.3% 0.4% 6.7% 12.8% 6.9% 2.0% -4.7% -5.4% 4.9% 14.2% 17.6% 22.2% 26.7% 27.0% 27.04%
OCF 5Y 15.8% 16.5% 14.9% 11.3% 10.8% 7.3% 5.4% 6.7% 9.2% 11.7% 9.2% 6.9% 4.9% 5.6% 8.6% 11.0% 13.0% 16.0% 15.3% 15.9% 15.86%
Assets 3Y 24.7% 24.7% 20.0% 20.0% 20.0% 20.0% 10.1% 10.1% 10.1% 10.1% 11.4% 11.4% 11.4% 11.4% 11.6% 11.6% 11.6% 11.6% 16.7% 16.7% 16.72%
Assets 5Y 17.9% 17.9% 15.9% 15.9% 15.9% 15.9% 17.6% 17.6% 17.6% 17.6% 14.5% 14.5% 14.5% 14.5% 14.1% 14.1% 14.1% 14.1% 13.1% 13.1% 13.06%
Equity 3Y 27.3% 27.3% 21.4% 21.4% 21.4% 21.4% 10.0% 10.0% 10.0% 10.0% 10.9% 10.9% 10.9% 10.9% 11.2% 11.2% 11.2% 11.2% 17.3% 17.3% 17.31%
Book Value 3Y 24.5% 26.3% 18.9% 20.5% 20.7% 21.1% 10.3% 10.4% 10.2% 10.4% 11.4% 11.1% 11.3% 11.3% 11.6% 11.4% 11.2% 11.1% 16.9% 16.9% 16.89%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.99 0.95 0.92 0.93 0.98 0.96 0.94 0.94 0.98 0.97 0.95 0.96 0.99 0.99 0.97 0.96 0.97 0.97 0.98 0.97 0.972
Earnings Stability 0.86 0.72 0.73 0.82 0.80 0.59 0.52 0.54 0.63 0.54 0.47 0.55 0.63 0.56 0.62 0.68 0.76 0.79 0.85 0.87 0.872
Margin Stability 0.98 0.98 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.99 0.99 0.99 1.00 0.995
Rev. Growth Consistency 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.83 0.50 0.50 0.84 0.95 0.93 0.91 0.92 1.00 0.96 0.86 0.50 0.81 0.81 0.88 0.90 0.90 0.91 0.91 0.92 0.919
Earnings Smoothness 0.65 0.54 0.53 0.67 0.88 0.80 0.75 0.78 0.99 0.90 0.70 0.59 0.62 0.61 0.75 0.78 0.78 0.80 0.79 0.82 0.816
ROE Trend 0.01 0.01 0.01 -0.01 -0.03 -0.03 -0.01 -0.01 -0.01 -0.01 0.00 0.02 0.03 0.04 0.01 0.02 0.02 0.01 0.02 0.02 0.017
Gross Margin Trend 0.00 0.01 0.02 0.01 0.00 -0.00 -0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.00 0.01 0.00 -0.00 -0.00 -0.01 -0.00 -0.004
FCF Margin Trend 0.07 0.11 0.04 -0.03 -0.07 -0.11 -0.13 -0.11 -0.09 -0.08 -0.12 -0.12 -0.14 -0.11 0.03 0.08 0.10 0.11 0.12 0.13 0.127
Sustainable Growth Rate 18.0% 18.7% 15.7% 15.1% 13.2% 12.7% 11.5% 11.4% 12.4% 13.2% 14.8% 16.3% 17.2% 18.4% 15.6% 16.7% 17.5% 18.5% 16.7% 17.4% 17.39%
Internal Growth Rate 18.4% 19.3% 16.0% 15.3% 13.1% 12.5% 11.1% 11.0% 12.0% 12.9% 14.5% 16.3% 17.3% 18.7% 15.7% 16.9% 17.9% 19.1% 16.9% 17.8% 17.78%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.18 1.27 1.23 1.12 1.21 1.18 1.13 1.25 1.30 1.33 1.01 0.86 0.79 0.81 1.04 1.10 1.08 1.08 1.06 1.13 1.128
FCF/OCF 0.86 0.88 0.83 0.79 0.74 0.66 0.64 0.61 0.63 0.62 0.41 0.35 0.25 0.32 0.54 0.64 0.71 0.77 0.82 0.84 0.843
FCF/Net Income snapshot only 0.951
OCF/EBITDA snapshot only 0.873
CapEx/Revenue 5.0% 4.8% 6.2% 6.6% 7.5% 8.9% 8.6% 9.8% 10.2% 11.2% 14.9% 15.2% 16.4% 15.7% 13.3% 11.3% 9.1% 7.2% 5.4% 5.0% 4.98%
CapEx/Depreciation snapshot only 0.982
Accruals Ratio -0.03 -0.04 -0.03 -0.02 -0.02 -0.02 -0.01 -0.02 -0.03 -0.04 -0.00 0.02 0.03 0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.019
Sloan Accruals snapshot only 0.095
Cash Flow Adequacy snapshot only 6.383
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 2.1% 2.0% 0.0% 6.5% 42.3% 1.2% 2.0% 2.2% 1.6% 89.1% 23.2% 3.3% 3.2% 3.0% 0.0% 0.0% 6.9% 76.2% 80.4% 1.1% 1.15%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.1% 0.8% 2.4% 2.8% 3.1% 1.9% 1.3% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 1.3% 1.1% 2.1% 2.06%
Net Buyback Yield -0.2% -0.2% -0.2% -0.1% 0.7% 2.3% 2.8% 3.1% 1.9% 1.1% 0.2% -0.2% -0.2% -0.2% -0.2% -0.2% -0.1% 1.1% 1.0% 1.9% 1.86%
Total Shareholder Return -0.2% -0.2% -0.2% -0.1% 0.7% 2.3% 2.8% 3.1% 1.9% 1.1% 0.2% -0.2% -0.2% -0.2% -0.2% -0.2% -0.1% 1.1% 1.0% 1.9% 1.86%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.92 0.90 0.90 0.89 0.83 0.83 0.82 0.81 0.83 0.83 0.92 0.96 0.94 0.94 0.87 0.88 0.87 0.87 0.86 0.83 0.831
Interest Burden (EBT/EBIT) 1.09 1.05 1.04 1.02 1.02 1.01 1.02 1.04 1.06 1.09 1.11 1.12 1.14 1.15 1.14 1.14 1.10 1.09 1.09 1.08 1.082
EBIT Margin 0.31 0.33 0.32 0.31 0.28 0.27 0.25 0.24 0.24 0.25 0.25 0.25 0.26 0.26 0.28 0.28 0.30 0.30 0.30 0.31 0.313
Asset Turnover 0.49 0.53 0.46 0.48 0.48 0.49 0.47 0.48 0.50 0.52 0.50 0.52 0.53 0.55 0.49 0.51 0.53 0.56 0.51 0.54 0.536
Equity Multiplier 1.16 1.16 1.14 1.14 1.14 1.14 1.15 1.15 1.15 1.15 1.17 1.17 1.17 1.17 1.15 1.15 1.15 1.15 1.15 1.15 1.152
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $4.45 $4.61 $4.64 $4.48 $3.94 $3.82 $3.70 $3.69 $3.99 $4.23 $5.02 $5.51 $5.80 $6.18 $6.38 $6.79 $7.16 $7.59 $7.92 $8.28 $8.28
Book Value/Share $26.75 $26.61 $32.53 $32.59 $32.84 $33.15 $30.93 $31.02 $30.90 $30.83 $37.15 $36.91 $36.86 $36.69 $45.16 $45.07 $45.14 $45.42 $49.46 $49.54 $49.58
Tangible Book/Share $25.62 $25.48 $31.40 $31.46 $31.70 $32.00 $29.81 $29.90 $29.79 $29.71 $36.07 $35.84 $35.79 $35.62 $44.14 $44.06 $44.12 $44.40 $48.40 $48.48 $48.48
Revenue/Share $14.15 $14.96 $15.54 $16.10 $16.39 $16.97 $17.43 $18.06 $18.65 $19.13 $19.89 $20.30 $20.98 $21.69 $22.95 $23.90 $25.12 $26.57 $27.93 $29.41 $29.82
FCF/Share $4.56 $5.14 $4.72 $3.94 $3.56 $2.98 $2.68 $2.83 $3.30 $3.51 $2.09 $1.65 $1.16 $1.62 $3.58 $4.79 $5.48 $6.28 $6.91 $7.88 $7.99
OCF/Share $5.27 $5.86 $5.69 $5.00 $4.78 $4.50 $4.18 $4.60 $5.20 $5.65 $5.06 $4.74 $4.61 $5.02 $6.64 $7.49 $7.76 $8.18 $8.41 $9.34 $9.47
Cash/Share $14.18 $14.10 $11.52 $11.54 $11.63 $11.74 $11.53 $11.57 $11.53 $11.50 $14.58 $14.49 $14.47 $14.40 $11.03 $11.01 $11.02 $11.09 $16.47 $16.49 $12.81
EBITDA/Share $5.24 $5.71 $5.80 $5.82 $5.58 $5.54 $5.44 $5.42 $5.62 $5.85 $6.11 $6.34 $6.66 $6.96 $7.72 $8.09 $8.95 $9.63 $10.30 $10.69 $10.69
Debt/Share $0.00 $0.00 $0.24 $0.24 $0.24 $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.40 $0.40 $0.40 $0.40 $0.84 $0.84 $0.84
Net Debt/Share $-14.18 $-14.10 $-11.28 $-11.30 $-11.39 $-11.49 $-11.53 $-11.57 $-11.53 $-11.50 $-14.58 $-14.49 $-14.47 $-14.40 $-10.63 $-10.61 $-10.62 $-10.69 $-15.63 $-15.65 $-15.65
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 38.973
Altman Z-Prime snapshot only 69.413
Piotroski F-Score 7 7 7 6 6 6 5 5 6 6 6 6 6 6 7 6 6 7 8 9 9
Beneish M-Score -2.46 -2.69 -2.13 -2.03 -2.08 -2.06 -2.47 -2.52 -2.55 -2.57 -2.35 -2.26 -2.24 -2.23 -2.17 -2.22 -2.19 -2.20 -2.40 -2.46 -2.458
Ohlson O-Score snapshot only -13.400
ROIC (Greenblatt) snapshot only 25.25%
Net-Net WC snapshot only $19.71
EVA snapshot only $1477920214.05
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA+
Credit Score 89.00 89.00 92.77 92.66 93.43 93.36 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 93.28 93.17 93.52 93.02 93.40 92.78 92.783
Credit Grade snapshot only 2
Credit Trend snapshot only -0.390
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 86
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms